The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
about
Use and safety of unfractionated heparin for anticoagulation during maintenance hemodialysisIncreased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin.Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.Investigation of a potential protective mechanism against heparin-induced thrombocytopenia in patients on chronic intermittent hemodialysis.Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.Inhibition of platelet activation could decrease thrombotic events in hemodialysis PF4/H antibody-positive patients.An update on heparin-induced thrombocytopenia: diagnosis and management.Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.Role of thrombophilia in vascular access thrombosis among chronic hemodialysis patients in Tunisia.Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin
P2860
Q27002491-38511014-0C75-4254-A21B-EE21243F8444Q33384050-D9869D55-7881-43C7-A3D6-B75E6AFD2847Q33399789-8EB4BC17-B3A1-4DFA-BCEA-1C36841C3967Q33405222-E8DB3D60-2223-456B-8A2E-D0166CE1B0F0Q33407198-9B1C198E-DD5F-4900-87FD-B4C70E8C0D46Q33414182-5276671D-CB14-4386-B13D-049F6847399EQ33430644-846B8185-B733-4CD9-A0CA-16402FFB42EAQ33431708-286FE28F-0BB7-4043-BF24-F92C9E9695A3Q33827427-3F69862D-53FD-43EB-A631-BB726A15F783Q39001581-3FDB1E76-D637-40A6-ABB1-0918833AF26EQ58741558-157AB321-18F0-4A9D-A169-A7E2E0C3D15A
P2860
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@ast
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@en
type
label
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@ast
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@en
prefLabel
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@ast
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@en
P2093
P50
P1433
P1476
The prevalence of antibodies t ...... ients on chronic hemodialysis.
@en
P2093
Jane C Moore
Marc A Rodger
Michael J Kovacs
P304
P356
10.1016/J.THROMRES.2006.09.014
P577
2006-11-13T00:00:00Z